Needle Biopsy Market Size, Trends, Growth, Scope and Forecast 2021-2030
According to Vision Research Reports, the global needle biopsy market size is projected to surpass around US$ 1.7 billion by 2030.
Needle biopsy is a clinical diagnostic procedure performed to acquire suspected sample of tissues from the body for the diagnosis and/or exclusion of different types of diseases. Tissue samples collected from biopsy devices are sent to diagnostic laboratories for analysis and diagnosis of different types of diseases. These tissue samples are analyzed to categorize or determine the staging of diseases and rule out the presence of specific diseases.
Key Driver
The global needle biopsy market is driven by the rise in prevalence of human and animal cancer across the globe, increase in global geriatric population, and government initiatives to spread awareness about cancer. North America dominated the global needle biopsy market in 2019, followed by Europe, and the trend is anticipated to continue during the forecast period. The region’s dominance can be ascribed to high prevalence and rise in incidence rate of breast and prostate cancer, a well-established healthcare industry, and awareness about cancer in the region.
Types of Needle Biopsy
Two basic types of needle biopsies are core needle biopsy and fine aspiration needle biopsy. Core needle biopsy is a hollow needle of size ranging from 11 to 18 gauge, and is used to acquire the tissue sample from breast, liver, prostate, and other organs. A local anesthesia is used to make the area numb prior to obtaining the tissue sample. Fine needle aspiration usually requires a small-sized hollow needle ranging from 22 to 27 gauge needle to obtain only a small portion of the lesion. Fine needle biopsy is most commonly used to acquire samples from thyroid.
Surge in Number of Cancer Cases Worldwide to Drive Market
The needle biopsy procedure is primarily deployed to diagnose prostate, skin, and breast cancer. Over the past couple of decades, the exponential rise in the number of cancer patients around the world is one of the primary factors due to which, the demand for needle biopsy has witnessed impressive growth. Moreover, the increasing demand for minimally invasive needle biopsy procedures is another major factor anticipated to augment the demand for needle biopsy during the forecast period. A notable surge in the number of breast cancer patients is expected to provide a massive boost to the adoption of needle biopsy procedures. This is another factor that is likely to provide considerable boost to the overall growth of the needle biopsy market during the forecast period.
Furthermore, the growing need to detect early signs of a preventable disease to improve survival rates of patients is another factor due to which, the demand for needle biopsy is on the rise.
Demand to Remain Steady During COVID-19 Pandemic
The COVID-19 pandemic has derailed the growth of several core industries as a result of stringent lockdowns and restrictions on transportation and trade. However, the medical sector is likely to largely remain unaffected due to the COVID-19 crisis, as manufacturing of medical devices, drugs, and medication are classified as ‘essential goods and services’. The demand for needle biopsy procedures has remained steady throughout 2020. Thus, the needle biopsy market is expected to exhibit a steady growth. Although the number of non-critical procedures has witnessed significant decline, the demand for minimally invasive needle biopsy procedures is expected to provide considerable boost to the overall prospects of the needle biopsy market in 2020.
Prominent Regions
In terms of region, the global needle biopsy market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global needle biopsy market in 2019, followed by Europe. The U.S. dominated the needle biopsy market in North America in 2019, due to the presence of key players, technological advancements, adoption of needle biopsy, and adequate reimbursement policies. This, in turn, is estimated to boost the market in the region. The needle biopsy market in Asia Pacific is likely to expand at a notable CAGR from 2020 to 2030. The expansion of the market in the region can be attributed to the adoption of new technologies such as fine-needle aspiration biopsy and core needle biopsy, high awareness, significant healthcare spending, early availability of advanced technologies, and high penetration of research activities across the region.
Global Needle Biopsy Market: Segmentation
Needle Biopsy Market, by Type
Fine-needle Aspiration Biopsy
Core Needle Biopsy
Needle Biopsy Market, by Application
Breast Cancer
Thyroid Cancer
Prostate Cancer
Transperineal
Transrectal
Liver Cancer
Others
Needle Biopsy Market, by End User
Hospitals
Diagnostics & Imaging Centers
Research Laboratories & Academic Institutes
Others
Needle Biopsy Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa
Scope of the Report
VRR’s report on the global needle biopsy market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period, 2020 to 2030 The report provides the overall Value (US$ Mn) and volume (units) of the global needle biopsy market for the period 2018–2030, considering 2020 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global needle biopsy market for the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global needle biopsy market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of the top-down and bottom-up approaches to study various phenomena in the global needle biopsy market.
The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on changing competitive dynamics in the global needle biopsy market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global needle biopsy market. The next section of the global needle biopsy market report highlights the USPs, which include breast cancer epidemiology, prostate cancer epidemiology, regulations related to premarket approval for new medical devices, regulations related to CE mark approval for new medical devices, overview of image guided needle biopsy, and impact of COVID-19 on the global needle biopsy market.
The report delves into the competition landscape of the global needle biopsy market. Key players operating in the global needle biopsy market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global needle biopsy market report.
Key Questions Answered in Needle Biopsy Market Report
Research Objectives and Research Approach
The comprehensive report on the global needle biopsy market begins with an overview of the market, followed by scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global needle biopsy market. It is followed by market introduction, market dynamics, and an overview of the global needle biopsy market, which include VRR analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the needle biopsy market. The next section of the global needle biopsy market report highlights the USPs, which include epidemiology of breast cancer epidemiology, prostate cancer epidemiology, regulations related to premarket approval for new medical devices, regulations related to CE mark approval for new medical devices, overview of image guided needle biopsy, and impact of COVID-19 on the global needle biopsy market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
Revenue generated by key biopsy needle manufacturers has been mapped to ascertain the size of the global needle biopsy market in terms of value. The forecast presented here assesses the total revenue generated in the needle biopsy market. In order to provide an accurate forecast, we initiated by sizing up the current needle biopsy market with the help of the parent market. Prices of different biopsy needles and number of biopsy procedures across different regions have been taken into consideration to drive the volume of biopsy needles during the forecast period.
The report analyzes the global needle biopsy market in terms of type, application, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global needle biopsy market.
Table of Content
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Needle Biopsy Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Needle Biopsy Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Overview of the Image Guided Needle Biopsy
5.3. Regulatory Scenario by Region/globally
5.4. COVID-19 Pandemics Impact on Global Needle Biopsy Market
6. Global Needle Biopsy Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Needle Biopsy Market Value & Volume Forecast, by Type, 2018–2030
6.3.1. Fine-Needle Aspiration Biopsy
6.3.2. Core Needle Biopsy
6.4. Market Attractiveness Analysis, by Type
7. Global Needle Biopsy Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Needle Biopsy Market Value Forecast, by Application, 2018–2030
7.3.1. Breast Cancer
7.3.2. Thyroid Cancer
7.3.3. Prostate Cancer
7.3.3.1. Transperineal
7.3.3.2. Transrectal
7.3.4. Liver Cancer
7.3.5. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Needle Biopsy Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Needle Biopsy Market Value Forecast, by End-user, 2018–2030
8.3.1. Hospitals
8.3.2. Diagnostics and Imaging Centers
8.3.3. Research Laboratories and Academic Institutes
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Needle Biopsy Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Needle Biopsy Market Value Forecast, by Region
9.2.1. Europe
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Needle Biopsy Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Needle Biopsy Market Value & Volume Forecast, by Type, 2018–2030
10.2.1. Fine-Needle Aspiration Biopsy
10.2.2. Core Needle Biopsy
10.3. North America Needle Biopsy Market Value Forecast, by Application, 2018–2030
10.3.1. Breast Cancer
10.3.2. Thyroid Cancer
10.3.3. Prostate Cancer
10.3.3.1. Transperineal
10.3.3.2. Transrectal
10.3.4. Liver Cancer
10.3.5. Others
10.4. North America Needle Biopsy Market Value Forecast, by End-user, 2018–2030
10.4.1. Hospitals
10.4.2. Diagnostics and Imaging Centers
10.4.3. Research Laboratories and Academic Institutes
10.4.4. Others
10.5. North America Needle Biopsy Market Value Forecast, by Country, 2018–2030
10.5.1. U.S.
10.5.2. Canada
10.6. North America Needle Biopsy Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Needle Biopsy Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Needle Biopsy Market Value & Volume Forecast, by Type, 2018–2030
11.2.1. Fine-Needle Aspiration Biopsy
11.2.2. Core Needle Biopsy
11.3. Europe Needle Biopsy Market Value & Volume Forecast, by Application, 2018–2030
11.3.1. Breast Cancer
11.3.2. Thyroid Cancer
11.3.3. Prostate Cancer
11.3.3.1. Transperineal
11.3.3.2. Transrectal
11.3.4. Liver Cancer
11.3.5. Others
11.4. Europe Needle Biopsy Market Value Forecast, by End-user, 2018–2030
11.4.1. Hospitals
11.4.2. Diagnostics and Imaging Centers
11.4.3. Research Laboratories and Academic Institutes
11.4.4. Others
11.5. Europe Needle Biopsy Market Value Forecast, by Country/Sub-region, 2018–2030
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Needle Biopsy Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Needle Biopsy Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Needle Biopsy Market Value & Volume Forecast, by Type, 2018–2030
12.2.1. Fine-Needle Aspiration Biopsy
12.2.2. Core Needle Biopsy
12.3. Asia Pacific Needle Biopsy Market Value Forecast, by Application, 2018–2030
12.3.1. Breast Cancer
12.3.2. Thyroid Cancer
12.3.3. Prostate Cancer
12.3.3.1. Transperineal
12.3.3.2. Transrectal
12.3.4. Liver Cancer
12.3.5. Others
12.4. Asia Pacific Needle Biopsy Market Value Forecast, by End-user, 2018–2030
12.4.1. Hospitals
12.4.2. Diagnostics and Imaging Centers
12.4.3. Research Laboratories and Academic Institutes
12.4.4. Others
12.5. Asia Pacific Needle Biopsy Market Value Forecast, by Country/Sub-region, 2018–2030
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Needle Biopsy Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Needle Biopsy Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Needle Biopsy Market Value & Volume Forecast, by Type, 2018–2030
13.2.1. Fine-Needle Aspiration Biopsy
13.2.2. Core Needle Biopsy
13.3. Latin America Needle Biopsy Market Value Forecast, by Application, 2018–2030
13.3.1. Breast Cancer
13.3.2. Thyroid Cancer
13.3.3. Prostate Cancer
13.3.3.1. Transperineal
13.3.3.2. Transrectal
13.3.4. Liver Cancer
13.3.5. Others
13.4. Latin America Needle Biopsy Market Value Forecast, by End-user, 2018–2030
13.4.1. Hospitals
13.4.2. Diagnostics and Imaging Centers
13.4.3. Research Laboratories and Academic Institutes
13.4.4. Others
13.5. Latin America Needle Biopsy Market Value Forecast, by Country/Sub-region, 2018–2030
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Needle Biopsy Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Needle Biopsy Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Needle Biopsy Market Value & Volume Forecast, by Type, 2018–2030
14.2.1. Fine-Needle Aspiration Biopsy
14.2.2. Core Needle Biopsy
14.3. Middle East & Africa Needle Biopsy Market Value Forecast, by Application, 2018–2030
14.3.1. Breast Cancer
14.3.2. Thyroid Cancer
14.3.3. Prostate Cancer
14.3.3.1. Transperineal
14.3.3.2. Transrectal
14.3.4. Liver Cancer
14.3.5. Others
14.4. Middle East & Africa Needle Biopsy Market Value Forecast, by End-user, 2018–2030
14.4.1. Hospitals
14.4.2. Diagnostics and Imaging Centers
14.4.3. Research Laboratories and Academic Institutes
14.4.4. Others
14.5. Middle East & Africa Needle Biopsy Market Value Forecast, by Country/Sub-region, 2018–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Needle Biopsy Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competitive Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Company Share Analysis
15.3. Company Profiles
15.3.1. Hologic, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Strategic Overview
15.3.1.5. SWOT Analysis
15.3.2. C. R. Bard, Inc. (Becton, Dickinson and Company).
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Strategic Overview
15.3.2.5. SWOT Analysis
15.3.3. INRAD, Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Strategic Overview
15.3.3.5. SWOT Analysis
15.3.4. Argon Medical
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Strategic Overview
15.3.4.5. SWOT Analysis
15.3.5. CONMED Corporation
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Strategic Overview
15.3.5.5. SWOT Analysis
15.3.6. Olympus Corporation
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Strategic Overview
15.3.6.5. SWOT Analysis
15.3.7. Stryker Corporation
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Strategic Overview
15.3.7.5. SWOT Analysis
15.3.8. Medtronic plc
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Strategic Overview
15.3.8.5. SWOT Analysis
15.3.9. Merit Medical Systems, Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. Strategic Overview
15.3.9.5. SWOT Analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers